Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

CANCIDAS POWDER FOR INJECTION 70 mg/vial

Approval Number

SIN11763P

Drug Name

CANCIDAS POWDER FOR INJECTION 70 mg/vial

Product Name

CANCIDAS POWDER FOR INJECTION 70 mg/vial

Approval Date

January 10, 2002

Registrant

MSD PHARMA (SINGAPORE) PTE. LTD.

Regulatory Information

Registrant

MSD PHARMA (SINGAPORE) PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

J02AX04

ATC Item Name

caspofungin

Manufacturer Information

Pharmaceutical Manufacturer

MSD PHARMA (SINGAPORE) PTE. LTD.

Manufacturers

FAREVA Mirabel (bulk production/primary & secondary packaging)

Active Ingredients

Ingredient Name

CASPOFUNGIN ACETATE EQV CASPOFUNGIN

Strength

70 mg/vial

Drug MonographCaspofungin

Documents

Package Inserts

Cancidas PI.pdf

Approved: August 18, 2022

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy